The West is practicing vaccine apartheid on a global level
China and India are the only two major countries that have been willing to export vaccines while also vaccinating their own people. Meanwhile, to rich countries, the billions of dollars of vaccine market for Big Pharma far outweigh the benefits of saving millions of lives
Covaxin trials: What 81% “interim efficacy” means
Bharat Biotech has claimed in a press release that its Covid-19 vaccine candidate, Covaxin, showed 81% efficacy in the “first interim analysis” of phase-3 trials.
In India, pseudo-nationalism trumps science in vaccine clearance
The recent regulatory clearance given to an indigenous developed vaccine candidate in India is an example of vaccine nationalism at its worst and jettisoning of all the principles of an evidence-based, scientific approach
Vaccine rollout battle: First past the post may win major market share
India’s mass vaccination plans may fail if it does not hold open discussions on its plans with health professionals and the people
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
- 26 million jobs were lost in Latin America and the Caribbean due to pandemic in one year, says ILO
- Syria asks UNSC to prevent Israel’s repeated attacks on its territory
- After 23-day hunger strike, undocumented workers in New York win USD 2.1 billion in assistance
- Palestinians welcome resumption of US aid to UNRWA
- US activists on hunger strike demand end to Yemen blockade
